Detalhe da pesquisa
1.
Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT Interval.
Endocr Pract
; 30(1): 11-18, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805100
2.
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study.
Headache
; 63(5): 683-691, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797223
3.
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER).
Clin Drug Investig
; 42(3): 263-275, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041159
4.
BayesWeb: a user-friendly platform for exploratory Bayesian analysis of safety signals from small clinical trials.
J Biopharm Stat
; 21(5): 1030-41, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21830929
5.
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial.
Adv Ther
; 38(11): 5465-5483, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34542830
6.
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER).
Clin Drug Investig
; 42(3): 277, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254628
7.
Bayesian sample-size determination for two independent Poisson rates.
Comput Methods Programs Biomed
; 104(2): 271-7, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21146897